| Schedule of details of non-controlling interests and movement |
| | | | | | | | | | | | | | | | | | | Millions of Euros | | | | | | | Profit / | | | | | | | | | | | | | | | Balance at | | (loss) for | | (Investments) / | | | | Other | | Translation | | Balance at | | | Reference | | 31/12/2024 | | the period | | Divestments | | Dividends | | movements | | differences | | 31/12/2025 | Grifols (Thailand) Pte Ltd | | | | 5 | | — | | — | | — | | — | | — | | 5 | Araclon Biotech, S.L. | | a) | | (1) | | — | | 2 | | — | | — | | — | | 1 | Haema GmbH | | | | 260 | | 11 | | — | | (87) | | — | | — | | 184 | BPC Plasma, Inc | | | | 146 | | 40 | | — | | (26) | | — | | (19) | | 141 | Grifols Diagnostic Solutions Inc. | | | | 1,970 | | 62 | | — | | (27) | | — | | (224) | | 1,781 | Plasmavita Healthcare GmbH | | | | 16 | | 3 | | — | | (1) | | 1 | | — | | 19 | Albimmune S.L. | | | | (3) | | — | | — | | — | | — | | — | | (3) | Biotest AG | | b) | | 330 | | (18) | | (112) | | — | | 3 | | 1 | | 204 | | | | | 2,723 | | 98 | | (110) | | (141) | | 4 | | (242) | | 2,332 |
| | | | | | | | | | | | | | | | | | | Millions of Euros | | | | | Balance at | | | | (Investments) / | | | | Other | | Translation | | Balance at | | | Reference | | 31/12/2023 | | Additions | | Divestments | | Dividends | | movements | | differences | | 31/12/2024 | Grifols (Thailand) Pte Ltd | | | | 5 | | — | | — | | — | | — | | — | | 5 | Grifols Malaysia Sdn Bhd | | | | 4 | | — | | (4) | | — | | — | | — | | — | Araclon Biotech, S.L. | | | | (1) | | — | | — | | — | | — | | — | | (1) | Haema GmbH | | | | 254 | | 6 | | — | | — | | — | | — | | 260 | BPC Plasma, Inc | | | | 148 | | 28 | | — | | (40) | | — | | 10 | | 146 | Grifols Diagnostic Solutions Inc. | | | | 1,347 | | 48 | | 508 | | (25) | | — | | 92 | | 1,970 | Plasmavita Healthcare GmbH | | | | 13 | | 4 | | — | | — | | — | | (1) | | 16 | Haema Plasma Kft | | Nota 2 (b) | | 20 | | — | | (20) | | — | | — | | — | | — | Albimmune S.L. | | | | (2) | | (1) | | — | | — | | — | | — | | (3) | Biotest AG | | | | 357 | | (29) | | — | | (1) | | — | | 3 | | 330 | | | | | 2,145 | | 56 | | 484 | | (66) | | — | | 104 | | 2,723 |
|
| Schedule of financial information on the non-controlling interests |
| | | | | | | | | | | | | | | | | Millions of Euros | | | 31/12/2025 | | | | | | | | | | | Total consolidated equity | | | | | | | Non-current | | Current | | Non-current | | Current | | (except for intercompany | | % Non-controlling | | Non-controlling | | | assets | | assets | | liabilities | | liabilities | | eliminations) | | Interest | | interests | Grupo Biotest | | 2,195 | | 876 | | (487) | | (854) | | 1,041 | | 19.6 | % | 204 | Grupo GDS | | 4,197 | | 251 | | (349) | | (141) | | 3,958 | | 45 | % | 1,781 | Haema GmbH | | 239 | | 46 | | (46) | | (41) | | 184 | | 100 | % | 184 | BPC Plasma, Inc | | 205 | | 33 | | (45) | | (22) | | 141 | | 100 | % | 141 | | | 6,836 | | 1,206 | | (927) | | (1,058) | | 5,324 | | | | 2,310 |
| | | | | | | | | | | | | | | | | Millions of Euros | | | 31/12/2024 | | | | | | | | | | | Total consolidated equity | | | | | | | Non-current | | Current | | Non-current | | Current | | (except for intercompany | | % Non-controlling | | Non-controlling | | | assets | | assets | | liabilities | | liabilities | | eliminations) | | Interest | | interests | Grupo Biotest | | 2,130 | | 780 | | (540) | | (657) | | 1,105 | | 29.8 | % | 330 | Grupo GDS | | 4,627 | | 253 | | (368) | | (134) | | 4,378 | | 45 | % | 1,970 | Haema GmbH | | 230 | | 121 | | (34) | | (50) | | 260 | | 100 | % | 260 | BPC Plasma, Inc | | 240 | | 26 | | (53) | | (22) | | 146 | | 100 | % | 146 | | | 7,227 | | 1,180 | | (995) | | (863) | | 5,889 | | | | 2,706 |
| | | | | | | | | | | | | | | | | | | Millions of Euros | | | 2025 | | 2024 | | | | | Consolidated | | % Non- | | Non- | | | | Consolidated | | % Non- | | Non- | | | Ordinary | | Net | | controlling | | controlling | | Ordinary | | Net | | controlling | | controlling | | | Income | | Income | | Interest | | interests | | Income | | Income | | Interest | | interests | Biotest group | | 675 | | (72) | | 19.6 | % | (18) | | 726 | | (96) | | 29.8 | % | (29) | GDS Group | | 571 | | 139 | | 45 | % | 62 | | 578 | | 122 | | 45 | % | 48 | Haema GmbH | | 219 | | 11 | | 100 | % | 11 | | 204 | | 6 | | 100 | % | 6 | BPC Plasma, Inc | | 224 | | 40 | | 100 | % | 40 | | 224 | | 28 | | 100 | % | 28 | | | 1,689 | | 118 | | | | 95 | | 1,732 | | 60 | | | | 53 |
|